Sign In

Login

Password

Forgot Password ? Sign Up

CD278 (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "CD278" in French language version.

Last modified:

Ref.Un. Ref.Website
Global rank French rank
88nih.gov
5th place
11th place
62ensembl.org
630th place
993rd place
55doi.org
2nd place
3rd place
11books.google.com
3rd place
8th place

books.google.com (Global: 3rd place; French: 8th place)

  • Frank R. Brennan, Handbook of Therapeutic Antibodies, Weinheim, Bergstr, Wiley-VCH, , 2e éd., 2544 p. (ISBN 978-3-527-32937-3, présentation en ligne), « T Cell Inhibitors in Phase 1 and 2 Clinical Studies for Immunological Disorders »

doi.org (Global: 2nd place; French: 3rd place)

dx.doi.org

  • Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, Kroczek RA, « ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28 », Nature, vol. 397, no 6716,‎ , p. 263–6 (PMID 9930702, DOI 10.1038/16717)
  • Yoshinaga SK, Whoriskey JS, Khare SD, Sarmiento U, Guo J, Horan T, Shih G, Zhang M, Coccia MA, Kohno T, Tafuri-Bladt A, Brankow D, Campbell P, Chang D, Chiu L, Dai T, Duncan G, Elliott GS, Hui A, McCabe SM, Scully S, Shahinian A, Shaklee CL, Van G, Mak TW, Senaldi G, « T-cell co-stimulation through B7RP-1 and ICOS », Nature, vol. 402, no 6763,‎ , p. 827–32 (PMID 10617205, DOI 10.1038/45582)
  • Rudd CE, Schneider H, « Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling », Nature Reviews. Immunology, vol. 3, no 7,‎ , p. 544–56 (PMID 12876557, DOI 10.1038/nri1131)
  • Dong C, Juedes AE, Temann UA, Shresta S, Allison JP, Ruddle NH, Flavell RA, « ICOS co-stimulatory receptor is essential for T-cell activation and function », Nature, vol. 409, no 6816,‎ , p. 97–101 (PMID 11343121, DOI 10.1038/35051100)
  • Sharma P, Allison JP, « The future of immune checkpoint therapy », Science, vol. 348, no 6230,‎ , p. 56–61 (PMID 25838373, DOI 10.1126/science.aaa8172)

ensembl.org (Global: 630th place; French: 993rd place)

may2017.archive.ensembl.org

nih.gov (Global: 5th place; French: 11th place)

ncbi.nlm.nih.gov

  • « Publications PubMed pour l'Homme », sur National Center for Biotechnology Information, U.S. National Library of Medicine
  • « Publications PubMed pour la Souris », sur National Center for Biotechnology Information, U.S. National Library of Medicine
  • Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, Kroczek RA, « ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28 », Nature, vol. 397, no 6716,‎ , p. 263–6 (PMID 9930702, DOI 10.1038/16717)
  • Yoshinaga SK, Whoriskey JS, Khare SD, Sarmiento U, Guo J, Horan T, Shih G, Zhang M, Coccia MA, Kohno T, Tafuri-Bladt A, Brankow D, Campbell P, Chang D, Chiu L, Dai T, Duncan G, Elliott GS, Hui A, McCabe SM, Scully S, Shahinian A, Shaklee CL, Van G, Mak TW, Senaldi G, « T-cell co-stimulation through B7RP-1 and ICOS », Nature, vol. 402, no 6763,‎ , p. 827–32 (PMID 10617205, DOI 10.1038/45582)
  • « Entrez Gene: ICOS inducible T-cell co-stimulator »
  • Rudd CE, Schneider H, « Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling », Nature Reviews. Immunology, vol. 3, no 7,‎ , p. 544–56 (PMID 12876557, DOI 10.1038/nri1131)
  • Dong C, Juedes AE, Temann UA, Shresta S, Allison JP, Ruddle NH, Flavell RA, « ICOS co-stimulatory receptor is essential for T-cell activation and function », Nature, vol. 409, no 6816,‎ , p. 97–101 (PMID 11343121, DOI 10.1038/35051100)
  • Sharma P, Allison JP, « The future of immune checkpoint therapy », Science, vol. 348, no 6230,‎ , p. 56–61 (PMID 25838373, DOI 10.1126/science.aaa8172)